Biovica International AB (publ) (STO:BIOVIC.B)

Biovica International AB Statistics

Total Valuation

STO:BIOVIC.B has a market cap or net worth of SEK 173.98 million. The enterprise value is 154.22 million.

Market Cap	173.98M
Enterprise Value	154.22M

Important Dates

The next estimated earnings date is Thursday, September 11, 2025.

Earnings Date	Sep 11, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:BIOVIC.B has 275.29 million shares outstanding. The number of shares has increased by 58.49% in one year.

Current Share Class	260.87M
Shares Outstanding	275.29M
Shares Change (YoY)	+58.49%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.07%
Owned by Institutions (%)	5.08%
Float	235.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.12
PB Ratio	4.03
P/TBV Ratio	4.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.76
EV / Sales	17.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.80

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.11.

Current Ratio	1.70
Quick Ratio	1.47
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	-397.03

Financial Efficiency

Return on equity (ROE) is -125.31% and return on invested capital (ROIC) is -72.33%.

Return on Equity (ROE)	-125.31%
Return on Assets (ROA)	-56.11%
Return on Invested Capital (ROIC)	-72.33%
Return on Capital Employed (ROCE)	-188.37%
Revenue Per Employee	320,259
Profits Per Employee	-3.25M
Employee Count	27
Asset Turnover	0.09
Inventory Turnover	0.26

Taxes

In the past 12 months, STO:BIOVIC.B has paid 1.64 million in taxes.

Income Tax	1.64M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.33% in the last 52 weeks. The beta is 1.48, so STO:BIOVIC.B's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	-76.33%
50-Day Moving Average	0.68
200-Day Moving Average	1.26
Relative Strength Index (RSI)	42.45
Average Volume (20 Days)	426,162

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:BIOVIC.B had revenue of SEK 8.65 million and -87.62 million in losses. Loss per share was -0.95.

Revenue	8.65M
Gross Profit	8.11M
Operating Income	-88.14M
Pretax Income	-85.98M
Net Income	-87.62M
EBITDA	-87.06M
EBIT	-88.14M
Loss Per Share	-0.95

Balance Sheet

The company has 24.42 million in cash and 4.65 million in debt, giving a net cash position of 19.76 million or 0.07 per share.

Cash & Cash Equivalents	24.42M
Total Debt	4.65M
Net Cash	19.76M
Net Cash Per Share	0.07
Equity (Book Value)	43.21M
Book Value Per Share	0.44
Working Capital	12.64M

Cash Flow

In the last 12 months, operating cash flow was -85.37 million and capital expenditures -287,000, giving a free cash flow of -85.65 million.

Operating Cash Flow	-85.37M
Capital Expenditures	-287,000
Free Cash Flow	-85.65M
FCF Per Share	-0.31

Margins

Gross Margin	93.81%
Operating Margin	-1,019.32%
Pretax Margin	-994.37%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

STO:BIOVIC.B does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-58.49%
Shareholder Yield	n/a
Earnings Yield	-50.36%
FCF Yield	-49.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:BIOVIC.B has an Altman Z-Score of -10.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.65
Piotroski F-Score	2